Mitochondrial ACSS1 Links Acetate Metabolism to Pyrimidine Biosynthesis in Nutrient-Stressed B-Cell Lymphomas.
Blocking an enzyme that lymphoma cells depend on under stress represents a potential new treatment target.
Researchers identified that B-cell lymphomas rely on the enzyme ACSS1 to convert acetate into building blocks for DNA synthesis under nutrient stress. This metabolic dependency represents a potential new drug target for lymphoma treatment.
What the study was
- Study design
- Preclinical (in vitro, metabolomics)
- Population
- B-cell lymphoma cell lines
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Cancer Letters
Why it surfaced
Novel metabolic vulnerability in B-cell lymphoma. Preclinical with potential translational relevance.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.